{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:38:35Z","timestamp":1740166715730,"version":"3.37.3"},"reference-count":116,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"S1","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Liver Disease"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1002\/cld.917","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T16:35:13Z","timestamp":1583166913000},"page":"S72-S81","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Autoimmune Hepatitis: Surviving Crises of Doubt and Elimination"],"prefix":"10.1097","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5024-3065","authenticated-orcid":false,"given":"Albert J.","family":"Czaja","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Mayo Clinic College of Medicine and Science,Rochester,MN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"cld917-bib-0001-20240115","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM195811132592001","article-title":"Hepatitis and cirrhosis in women with positive clot tests for lupus erythematosus","volume":"259","year":"1958","journal-title":"N Engl J Med"},{"key":"cld917-bib-0002-20240115","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0016-5085(19)33286-X","article-title":"\u201cLupoid\u201d hepatitis, a nonentity in the spectrum of chronic active liver disease","volume":"63","year":"1972","journal-title":"Gastroenterology"},{"key":"cld917-bib-0003-20240115","first-page":"95","article-title":"How lupoid is lupoid hepatitis?","volume":"13","year":"1986","journal-title":"J Rheumatol"},{"key":"cld917-bib-0004-20240115","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1440-1746.1990.tb01636.x","article-title":"Auto\u2010immune chronic active hepatitis: a specific entity? The negative argument","volume":"5","year":"1990","journal-title":"J Gastroenterol Hepatol"},{"key":"cld917-bib-0005-20240115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/jcem-11-2-152","article-title":"Adrenal cortical metabolism in chronic liver disease","volume":"11","year":"1951","journal-title":"J Clin Endocrinol Metab"},{"key":"cld917-bib-0006-20240115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(56)90003-1","article-title":"The problem of chronic liver disease in young women","volume":"21","year":"1956","journal-title":"Am J Med"},{"key":"cld917-bib-0007-20240115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0002-9343(61)90090-0","article-title":"Chronic liver disease in young people. Clinical features and course in thirty\u2010three patients","volume":"30","year":"1961","journal-title":"Am J Med"},{"key":"cld917-bib-0008-20240115","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/gut.4.4.378","article-title":"Active \u2018juvenile\u2019 cirrhosis considered as part of a systemic disease and the effect of corticosteroid therapy","volume":"4","year":"1963","journal-title":"Gut"},{"key":"cld917-bib-0009-20240115","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0016-5085(76)80332-0","article-title":"Chronic hepatitis\u2014a perspective on classification and determinants of prognosis","volume":"70","year":"1976","journal-title":"Gastroenterology"},{"key":"cld917-bib-0010-20240115","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","year":"1994","journal-title":"Hepatology"},{"key":"cld917-bib-0011-20240115","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJM197110072851501","article-title":"Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin","volume":"285","year":"1971","journal-title":"N Engl J Med"},{"key":"cld917-bib-0012-20240115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01071970","article-title":"Drug\u2010induced active chronic hepatitis","volume":"18","year":"1973","journal-title":"Am J Dig Dis"},{"key":"cld917-bib-0013-20240115","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/gut.17.10.781","article-title":"Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen","volume":"17","year":"1976","journal-title":"Gut"},{"key":"cld917-bib-0014-20240115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2008-1040723","article-title":"Drug\u2010induced chronic liver disease, with emphasis on chronic active hepatitis","volume":"1","year":"1981","journal-title":"Semin Liver Dis"},{"key":"cld917-bib-0015-20240115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0168-8278(91)90082-M","article-title":"Hepatitis C virus replication in \u2018autoimmune\u2019 chronic hepatitis","volume":"13","year":"1991","journal-title":"J Hepatol"},{"key":"cld917-bib-0016-20240115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0168-8278(91)90864-8","article-title":"Is autoimmune chronic active hepatitis a HCV\u2010related disease?","volume":"13","year":"1991","journal-title":"J Hepatol"},{"key":"cld917-bib-0017-20240115","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0168-8278(05)80279-X","article-title":"Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States","volume":"18","year":"1993","journal-title":"J Hepatol"},{"key":"cld917-bib-0018-20240115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02063938","article-title":"Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis","volume":"40","year":"1995","journal-title":"Dig Dis Sci"},{"key":"cld917-bib-0019-20240115","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/0016-5085(93)90656-W","article-title":"The nature and prognosis of severe cryptogenic chronic active hepatitis","volume":"104","year":"1993","journal-title":"Gastroenterology"},{"key":"cld917-bib-0020-20240115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","article-title":"The variant forms of autoimmune hepatitis","volume":"125","year":"1996","journal-title":"Ann Intern Med"},{"key":"cld917-bib-0021-20240115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0028-1109146","article-title":"Presumed cryptogenic liver disease in Germany: high prevalence of autoantibody\u2010negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology","volume":"47","year":"2009","journal-title":"Z Gastroenterol"},{"key":"cld917-bib-0022-20240115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-010-1501-1","article-title":"Performance parameters of the conventional serological markers for autoimmune hepatitis","volume":"56","year":"2011","journal-title":"Dig Dis Sci"},{"key":"cld917-bib-0023-20240115","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1053\/j.gastro.2011.04.026","article-title":"Autoimmune hepatitis: the dilemma of rare diseases","volume":"140","year":"2011","journal-title":"Gastroenterology"},{"key":"cld917-bib-0024-20240115","first-page":"1323","article-title":"Lupoid hepatitis","volume":"271","year":"1956","journal-title":"Lancet"},{"key":"cld917-bib-0025-20240115","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/hep.510380643","article-title":"A sheep in wolf's clothing","volume":"38","year":"2003","journal-title":"Hepatology"},{"key":"cld917-bib-0026-20240115","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0016-5085(19)33990-3","article-title":"Classification and treatment of chronic active liver disease","volume":"55","year":"1968","journal-title":"Gastroenterology"},{"key":"cld917-bib-0027-20240115","first-page":"183","article-title":"Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution","volume":"3","year":"1972","journal-title":"Hum Pathol"},{"key":"cld917-bib-0028-20240115","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.1840040409","article-title":"Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg\u2010negative chronic active hepatitis","volume":"4","year":"1984","journal-title":"Hepatology"},{"key":"cld917-bib-0029-20240115","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1053\/jhep.2002.0351554","article-title":"Where are the gnomes of yesteryear?","volume":"35","year":"2002","journal-title":"Hepatology"},{"key":"cld917-bib-0030-20240115","first-page":"65","article-title":"Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus","volume":"1","year":"1959","journal-title":"Lancet"},{"key":"cld917-bib-0031-20240115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/path.1700750218","article-title":"Hepatitis complicated by manifestations of lupus erythematosus","volume":"75","year":"1958","journal-title":"J Pathol Bacteriol"},{"key":"cld917-bib-0032-20240115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0016-5085(19)34917-0","article-title":"The course and treatment of lupoid hepatitis","volume":"45","year":"1963","journal-title":"Gastroenterology"},{"key":"cld917-bib-0033-20240115","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.1957.02980130015004","article-title":"Chronic thyroiditis and autoimmunization","volume":"164","year":"1957","journal-title":"J Am Med Assoc"},{"key":"cld917-bib-0034-20240115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1749-6632.1966.tb45493.x","article-title":"Concept of autoimmune disease","volume":"135","year":"1966","journal-title":"Ann N Y Acad Sci"},{"key":"cld917-bib-0035-20240115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0300-2977(96)00003-4","article-title":"The spectrum of liver disease in systemic lupus erythematosus","volume":"48","year":"1996","journal-title":"Neth J Med"},{"key":"cld917-bib-0036-20240115","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","year":"1972","journal-title":"Gastroenterology"},{"key":"cld917-bib-0037-20240115","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","article-title":"Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared","volume":"16","year":"1975","journal-title":"Gut"},{"key":"cld917-bib-0038-20240115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis","volume":"40","year":"1971","journal-title":"Q J Med"},{"key":"cld917-bib-0039-20240115","first-page":"735","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","year":"1973","journal-title":"Lancet"},{"key":"cld917-bib-0040-20240115","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","year":"1999","journal-title":"J Hepatol"},{"key":"cld917-bib-0041-20240115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0016-5085(19)34365-3","article-title":"Smooth muscle autoantibody in \u201cautoimmune\u201d hepatitis","volume":"51","year":"1966","journal-title":"Gastroenterology"},{"key":"cld917-bib-0042-20240115","first-page":"237","article-title":"Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications","volume":"1","year":"1966","journal-title":"Clin Exp Immunol"},{"key":"cld917-bib-0043-20240115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.111.2.285","article-title":"Immunocytochemical study of gamma globulin in liver in hepatitis and postnecrotic cirrhosis","volume":"111","year":"1960","journal-title":"J Exp Med"},{"key":"cld917-bib-0044-20240115","first-page":"150","article-title":"Local formation of gamma\u2010globulin in the diseased liver, and its relation to hepatic necrosis","volume":"11","year":"1962","journal-title":"Lab Invest"},{"key":"cld917-bib-0045-20240115","first-page":"827","article-title":"The nature of piecemeal necrosis in chronic active hepatitis","volume":"2","year":"1979","journal-title":"Lancet"},{"key":"cld917-bib-0046-20240115","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","article-title":"Acute and acute severe (fulminant) autoimmune hepatitis","volume":"58","year":"2013","journal-title":"Dig Dis Sci"},{"key":"cld917-bib-0047-20240115","first-page":"53","article-title":"Prognosis of chronic persistent hepatitis","volume":"1","year":"1970","journal-title":"Lancet"},{"key":"cld917-bib-0048-20240115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM198101013040102","article-title":"Corticosteroid\u2010treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis","volume":"304","year":"1981","journal-title":"N Engl J Med"},{"key":"cld917-bib-0049-20240115","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/0016-5085(84)90186-0","article-title":"Development and prognosis of histologic cirrhosis in corticosteroid\u2010treated hepatitis B surface antigen\u2010negative chronic active hepatitis","volume":"87","year":"1984","journal-title":"Gastroenterology"},{"key":"cld917-bib-0050-20240115","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis","volume":"110","year":"1996","journal-title":"Gastroenterology"},{"key":"cld917-bib-0051-20240115","doi-asserted-by":"crossref","first-page":"981","DOI":"10.7326\/0003-4819-127-11-199712010-00006","article-title":"Reversibility of hepatic fibrosis in autoimmune hepatitis","volume":"127","year":"1997","journal-title":"Ann Intern Med"},{"key":"cld917-bib-0052-20240115","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00004836-200105000-00014","article-title":"Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy","volume":"32","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"cld917-bib-0053-20240115","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/BF02235164","article-title":"Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy","volume":"16","year":"1971","journal-title":"Am J Dig Dis"},{"key":"cld917-bib-0054-20240115","first-page":"183","article-title":"Cirrhosis of the liver: A reversible disease?","volume":"14","year":"1979","journal-title":"Pathol Annu"},{"key":"cld917-bib-0055-20240115","first-page":"1599","article-title":"Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis","volume":"124","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"cld917-bib-0056-20240115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00004836-200105000-00001","article-title":"Use of corticosteroid therapy in autoimmune hepatitis resulting in the resolution of cirrhosis","volume":"32","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"cld917-bib-0057-20240115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0016-5085(03)00973-9","article-title":"Reversal of cirrhosis: evidence\u2010based medicine?","volume":"125","year":"2003","journal-title":"Gastroenterology"},{"key":"cld917-bib-0058-20240115","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","year":"1995","journal-title":"J Hepatol"},{"key":"cld917-bib-0059-20240115","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jhep.2004.01.009","article-title":"Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis","volume":"40","year":"2004","journal-title":"J Hepatol"},{"key":"cld917-bib-0060-20240115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.1965.03080070025007","article-title":"A \u201cnew\u201d antigen in leukemia sera","volume":"191","year":"1965","journal-title":"JAMA"},{"key":"cld917-bib-0061-20240115","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug\u2010induced autoimmune\u2010like hepatitis","volume":"56","year":"2011","journal-title":"Dig Dis Sci"},{"key":"cld917-bib-0062-20240115","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug\u2010induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"cld917-bib-0063-20240115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood\u2010borne non\u2010A, non\u2010B viral hepatitis genome","volume":"244","year":"1989","journal-title":"Science"},{"key":"cld917-bib-0064-20240115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"cld917-bib-0065-20240115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0140-6736(90)90070-L","article-title":"Type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"cld917-bib-0066-20240115","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/0140-6736(90)90870-B","article-title":"Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false\u2010positive result?","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"cld917-bib-0067-20240115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jmv.1890420113","article-title":"Virus\u2010induced autoimmunity in hepatitis C virus infections: a rare event","volume":"42","year":"1994","journal-title":"J Med Virol"},{"key":"cld917-bib-0068-20240115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gut.37.3.406","article-title":"Heterogeneity of liver\/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease","volume":"37","year":"1995","journal-title":"Gut"},{"key":"cld917-bib-0069-20240115","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"cld917-bib-0070-20240115","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","year":"2011","journal-title":"Gut"},{"key":"cld917-bib-0071-20240115","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"Autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"cld917-bib-0072-20240115","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"cld917-bib-0073-20240115","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis","volume":"7","year":"1987","journal-title":"Hepatology"},{"key":"cld917-bib-0074-20240115","first-page":"292","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","year":"1987","journal-title":"Lancet"},{"key":"cld917-bib-0075-20240115","first-page":"1206","article-title":"The validity and importance of subtypes in autoimmune hepatitis: a point of view","volume":"90","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"cld917-bib-0076-20240115","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1572-0241.2007.01153.x","article-title":"Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse","volume":"102","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"cld917-bib-0077-20240115","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","year":"2010","journal-title":"Gastroenterology"},{"key":"cld917-bib-0078-20240115","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s10620-018-5011-x","article-title":"Tacrolimus and mycophenolate mofetil as second\u2010line therapies for pediatric patients with autoimmune hepatitis","volume":"63","year":"2018","journal-title":"Dig Dis Sci"},{"key":"cld917-bib-0079-20240115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/gast.1996.v110.pm8536867","article-title":"The successful treatment of autoimmune hepatitis with 6\u2010mercaptopurine after failure with azathioprine","volume":"110","year":"1996","journal-title":"Gastroenterology"},{"key":"cld917-bib-0080-20240115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cgh.2015.09.037","article-title":"Efficacy of 6\u2010mercaptopurine as second\u2010line treatment for patients with autoimmune hepatitis and azathioprine intolerance","volume":"14","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"cld917-bib-0081-20240115","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/egh.12.38","article-title":"Drug choices in autoimmune hepatitis: part B\u2014nonsteroids","volume":"6","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"cld917-bib-0082-20240115","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1155\/2012\/512132","article-title":"Autoimmune hepatitis: focusing on treatments other than steroids","volume":"26","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"cld917-bib-0083-20240115","first-page":"793","article-title":"Association of autoimmune active chronic hepatitis with HL\u2010A1,8","volume":"2","year":"1972","journal-title":"Lancet"},{"key":"cld917-bib-0084-20240115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1399-0039.1977.tb01077.x","article-title":"HLA determinants in chronic active liver disease: possible relation of HLA\u2010Dw3 to prognosis","volume":"9","year":"1977","journal-title":"Tissue Antigens"},{"key":"cld917-bib-0085-20240115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-8278(85)80051-9","article-title":"HLA A1\u2010B8\u2010DR3 and suppressor cell function in first\u2010degree relatives of patients with autoimmune chronic active hepatitis","volume":"1","year":"1985","journal-title":"J Hepatol"},{"key":"cld917-bib-0086-20240115","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1\u2010B8\u2010DR3 are independent risk factors","volume":"13","year":"1991","journal-title":"Hepatology"},{"key":"cld917-bib-0087-20240115","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","article-title":"Allelic basis for HLA\u2010encoded susceptibility to type 1 autoimmune hepatitis","volume":"112","year":"1997","journal-title":"Gastroenterology"},{"key":"cld917-bib-0088-20240115","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/hep.21518","article-title":"A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1","volume":"45","year":"2007","journal-title":"Hepatology"},{"key":"cld917-bib-0089-20240115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome\u2010wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","year":"2014","journal-title":"Gastroenterology"},{"key":"cld917-bib-0090-20240115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/gene.2014.82","article-title":"HLA\u2010DRB1*03:01 and HLA\u2010DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type\u20101","volume":"16","year":"2015","journal-title":"Genes Immun"},{"key":"cld917-bib-0091-20240115","doi-asserted-by":"crossref","first-page":"9257","DOI":"10.3748\/wjg.v22.i42.9257","article-title":"Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis","volume":"22","year":"2016","journal-title":"World J Gastroenterol"},{"key":"cld917-bib-0092-20240115","article-title":"Epigenetic changes and their implications in autoimmune hepatitis","volume":"48","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"cld917-bib-0093-20240115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20\u2010year experience","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"cld917-bib-0094-20240115","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"cld917-bib-0095-20240115","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1572-0241.2002.05921.x","article-title":"Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis","volume":"97","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"cld917-bib-0096-20240115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/egh.13.21","article-title":"Autoimmune hepatitis in diverse ethnic populations and geographical regions","volume":"7","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"cld917-bib-0097-20240115","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s10620-017-4675-y","article-title":"Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis","volume":"62","year":"2017","journal-title":"Dig Dis Sci"},{"key":"cld917-bib-0098-20240115","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00007890-198404000-00009","article-title":"Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting","volume":"37","year":"1984","journal-title":"Transplantation"},{"key":"cld917-bib-0099-20240115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De\u2010novo autoimmune hepatitis after liver transplantation","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"cld917-bib-0100-20240115","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"key":"cld917-bib-0101-20240115","first-page":"1233","article-title":"Acute\u2010onset autoimmune hepatitis resembling acute hepatitis: a case report and review of reported cases","volume":"52","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"cld917-bib-0102-20240115","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1007\/s10620-015-3708-7","article-title":"Transitioning from idiopathic to explainable autoimmune hepatitis","volume":"60","year":"2015","journal-title":"Dig Dis Sci"},{"key":"cld917-bib-0103-20240115","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/s10620-018-5072-x","article-title":"Under\u2010evaluated or unassessed pathogenic pathways in autoimmune hepatitis and implications for future management","volume":"63","year":"2018","journal-title":"Dig Dis Sci"},{"key":"cld917-bib-0104-20240115","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s10620-018-5351-6","article-title":"Evolving role of vitamin D in immune\u2010mediated disease and its implications in autoimmune hepatitis","volume":"64","year":"2019","journal-title":"Dig Dis Sci"},{"key":"cld917-bib-0105-20240115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/08916934.2019.1641200","article-title":"Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis","volume":"52","year":"2019","journal-title":"Autoimmunity"},{"key":"cld917-bib-0106-20240115","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/1744666X.2017.1319764","article-title":"Evolving paradigm for treatment of autoimmune hepatitis","volume":"13","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"cld917-bib-0107-20240115","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/apt.14324","article-title":"Review article: next\u2010generation transformative advances in the pathogenesis and management of autoimmune hepatitis","volume":"46","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"cld917-bib-0108-20240115","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult\u2010to\u2010treat autoimmune hepatitis","volume":"58","year":"2013","journal-title":"J Hepatol"},{"key":"cld917-bib-0109-20240115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2013\/512624","article-title":"Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy","volume":"27","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"cld917-bib-0110-20240115","article-title":"B\u2010cell activating factor belonging to the tumor necrosis factor family and interferon\u2010gamma\u2010inducible protein\u201010 in autoimmune hepatitis","volume":"95","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"cld917-bib-0111-20240115","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s10620-011-2017-z","article-title":"Autoantibody\u2010negative autoimmune hepatitis","volume":"57","year":"2012","journal-title":"Dig Dis Sci"},{"key":"cld917-bib-0112-20240115","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2013.08.039","article-title":"Cholestatic phenotypes of autoimmune hepatitis","volume":"12","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"cld917-bib-0113-20240115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cgh.2015.07.017","article-title":"Features and progression of asymptomatic autoimmune hepatitis in Italy","volume":"14","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"cld917-bib-0114-20240115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/lt.25375","article-title":"Recurrent and de novo autoimmune hepatitis","volume":"25","year":"2019","journal-title":"Liver Transpl"},{"key":"cld917-bib-0115-20240115","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","year":"2010","journal-title":"Hepatology"},{"journal-title":"The Rheumatologist","key":"cld917-bib-0116-20240115","article-title":"He taught us to always go deeper"}],"container-title":["Clinical Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcld.917","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cld.917","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cld.917","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/cld.917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T17:05:45Z","timestamp":1705338345000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/cld.917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":116,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1002\/cld.917","relation":{},"ISSN":["2046-2484","2046-2484"],"issn-type":[{"type":"print","value":"2046-2484"},{"type":"electronic","value":"2046-2484"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"2019-09-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}